View Rule

View EO 12866 Meetings Printer-Friendly Version     Download RIN Data in XML
HHS/CDC RIN: 0920-AA85 Publication ID: Spring 2025 
Title: Import Regulations for Infectious Biological Agents, Infectious Substances, Vectors, and Nucleic Acids Capable of Producing Infectious Viruses 
Abstract:

This proposed rulemaking will clarify import permit requirements for those who intend to apply for an import permit. The rulemaking will improve HHS/CDC’s ability to prevent the introduction, transmission, or spread of communicable disease into the United States. This proposed rule seeks to strengthen border and import controls, prevent bioterrorism by allowing authorities to track and monitor high-risk materials, and better coordinate with Federal partners who enforce border security and control.

 
Agency: Department of Health and Human Services(HHS)  Priority: Other Significant 
RIN Status: Previously published in the Unified Agenda Agenda Stage of Rulemaking: Proposed Rule Stage 
Major: No  Unfunded Mandates: No 
EO 14192 Designation: Other 
CFR Citation: 42 CFR 71.54   
Legal Authority: 42 U.S.C. 264   
Legal Deadline:  None
Timetable:
Action Date FR Cite
NPRM  11/00/2025 
Regulatory Flexibility Analysis Required: No  Government Levels Affected: None 
Federalism: No 
Included in the Regulatory Plan: No 
International Impacts: This regulatory action will be likely to have international trade and investment effects, or otherwise be of international interest.
RIN Data Printed in the FR: No 
Agency Contact:
Shelley Jorgensen
Director, Division of Regulatory Science and Compliance
Department of Health and Human Services
Centers for Disease Control and Prevention
1600 Clifton Road NE, H21-54,
Atlanta, GA 30329
Phone:404 718-2000
Email: lrsat@cdc.gov